Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Sep. 24, 2021
Current assets:
Cash and cash equivalents	$ 1,056,686	$ 1,225,380
Restricted cash	7,746	7,652
Short-term investments	80,618	38,839
Accounts receivable, net of allowance for credit losses of $9,900 and $8,744	241,449	232,609
Contract assets, net of allowance for credit losses of $144 and $208	226,809	182,316
Inventories, net	13,144	10,965
Prepaid expenses and other current assets	68,693	62,737
Total current assets	1,695,145	1,760,498
Long-term investments	120,988	62,819
Property, plant and equipment, net	533,706	534,381
Operating lease right-of-use assets	63,141	67,128
Intangible assets, net	125,804	122,890
Goodwill	339,897	340,694
Other non-current assets	61,331	61,257
Deferred taxes	164,909	156,020
Total assets	3,104,921	3,105,687
Current liabilities:
Accounts payable	19,104	17,779
Accrued liabilities	225,847	262,728
Income taxes payable	1,601	1,334
Contract liabilities	21,426	18,473
Operating lease liabilities	15,312	15,403
Total current liabilities	283,290	315,717
Non-current contract liabilities	24,117	23,713
Non-current operating lease liabilities	52,615	56,715
Other non-current liabilities	102,378	105,310
Total liabilities	462,400	501,455
Stockholders’ equity:
Retained earnings	2,649,175	2,607,909
Accumulated other comprehensive loss	(11,521)	(10,030)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,637,754	2,597,979
Controlling interest	4,767	6,253
Total stockholders’ equity	2,642,521	2,604,232
Total liabilities and stockholders’ equity	3,104,921	3,105,687
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 65,627,314 shares issued and outstanding at December 31, 2021 and 64,986,316 at September 24, 2021
Stockholders’ equity:
Common stock	59	59
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,086,629 shares issued and outstanding at December 31, 2021 and 36,086,779 at September 24, 2021
Stockholders’ equity:
Common stock	$ 41	$ 41